Based on evidence that a NAB2-STAT6 gene fusion is present in most SFT cases, NAB2 and STAT6 IHC have recently been reported in 100 % [24, 33] and 86–100 % [23–26, 29] of SFT cases. This evidence concerns the gene STAT6 and solitary fibrous tumor.